MedTrace Logo

Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics

NCT02717273 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2018-07-17

Study results available
· View outcomes & findings →

Summary

This study will be to prospectively determine differences in Surgical Site Infection (SSI) if a prolonged course of post-operative antibiotics are used following liver transplantation.

Conditions

  • Liver Transplantation
  • Surgical Site Infection

Interventions

DRUG

standard

peri-operative antibiotic regimen only

DRUG

extended

extended three-day course of antibiotics

OTHER

liver transplant

orthotopic liver transplantation

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Virginia

    lead OTHER

Principal Investigators

  • Robert G Sawyer, MD · UVA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02717273 on ClinicalTrials.gov